Ontology highlight
ABSTRACT: Importance
The US Department of Health and Human Services (HHS) has proposed to reform drug pricing in Medicare Part B, which primarily covers physician-administered drugs and biologic agents. One HHS proposal would shift coverage of certain drugs from Medicare Part B to Part D, which is administered by private prescription drug plans.Objective
To estimate the association of changes of a shift in Medicare Part B to Part D with total drug spending and patient cost-sharing.Design, setting, and participants
Retrospective drug cohort study of the 75 brand-name drugs associated with the highest Part B expenditures among fee-for-service Medicare beneficiaries in 2016.Main outcomes and measures
Estimated total Medicare spending in Part B and Part D; annual out-of-p
SUBMITTER: Hwang TJ
PROVIDER: S-EPMC6439690 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature